These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10777145)

  • 1. Expression of the novel T cell activation molecule hpH4 in HIV-infected patients: correlation with disease status.
    Lucia MB; Buonfiglio D; Bottarel F; Bensi T; Rutella S; Rumi C; Ortona L; Janeway CA; Cauda R; Dianzani U
    AIDS Res Hum Retroviruses; 2000 Apr; 16(6):549-57. PubMed ID: 10777145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy.
    Kovacs JA; Vogel S; Metcalf JA; Baseler M; Stevens R; Adelsberger J; Lempicki R; Hengel RL; Sereti I; Lambert L; Dewar RL; Davey RT; Walker RE; Falloon J; Polis MA; Masur H; Lane HC
    Eur J Immunol; 2001 May; 31(5):1351-60. PubMed ID: 11465092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes.
    Plaeger S; Bass HZ; Nishanian P; Thomas J; Aziz N; Detels R; King J; Cumberland W; Kemeny M; Fahey JL
    Clin Immunol; 1999 Feb; 90(2):238-46. PubMed ID: 10080836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
    de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
    Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
    Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
    AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive infection in a subset of HIV-1-positive chimpanzees.
    O'Neil SP; Novembre FJ; Hill AB; Suwyn C; Hart CE; Evans-Strickfaden T; Anderson DC; deRosayro J; Herndon JG; Saucier M; McClure HM
    J Infect Dis; 2000 Oct; 182(4):1051-62. PubMed ID: 10979899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
    Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
    Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
    Liu Z; Cumberland WG; Hultin LE; Prince HE; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):83-92. PubMed ID: 9358102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion.
    Gascon RL; Narváez AB; Zhang R; Kahn JO; Hecht FM; Herndier BG; McGrath MS
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):146-53. PubMed ID: 12045676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children.
    Paul ME; Shearer WT; Kozinetz CA; Lewis DE
    J Allergy Clin Immunol; 2001 Aug; 108(2):258-64. PubMed ID: 11496243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans.
    Hengel RL; Jones BM; Kennedy MS; Hubbard MR; McDougal JS
    J Immunol; 1999 Sep; 163(6):3539-48. PubMed ID: 10477629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
    Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
    Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
    Lenkei R; Bratt G; Holmberg V; Muirhead K; Sandström E
    Cytometry; 1998 Oct; 33(2):115-22. PubMed ID: 9773871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of surface transferrin receptors in lymphoid cells de novo infected with human immunodeficiency virus type-1.
    Savarino A; Calosso L; Piragino A; Martini C; Gennero L; Pescarmona GP; Pugliese A
    Cell Biochem Funct; 1999 Mar; 17(1):47-55. PubMed ID: 10191508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
    Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
    Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
    Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
    Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
    Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
    J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotypic analysis of HIV-infected children: alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets.
    McCloskey TW; Kohn N; Lesser M; Bakshi S; Pahwa S
    Cytometry; 2001 Jun; 46(3):157-65. PubMed ID: 11449406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator.
    Hultin LE; Matud JL; Giorgi JV
    Cytometry; 1998 Oct; 33(2):123-32. PubMed ID: 9773872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study.
    Bürgisser P; Hammann C; Kaufmann D; Battegay M; Rutschmann OT
    Clin Exp Immunol; 1999 Mar; 115(3):458-63. PubMed ID: 10193418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.